MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call
22 juil. 2021 16h05 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
16 juin 2021 07h30 HE
|
MacroGenics, Inc.
Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific moleculesMacroGenics provides rights to Zai Lab for its DART® and TRIDENT® multi-specific...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
19 mai 2021 17h05 HE
|
MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
MacroGenics to Participate in Upcoming Investor Conference
19 mai 2021 07h00 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, May 19, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Zenas BioPharma ประกาศแต่งตั้งผู้บริหารระดับสูงคนใหม่
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. แต่งตั้งให้ดำรงตำแหน่งประธาน, CEO และรักษาการ CMO Joe Farmer แต่งตั้งให้ดำรงตำแหน่ง CBO ฮ่องกงและบอสตัน, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (ต่อไปนี้จะเรียกว่า...
Zenas BioPharma Anuncia Novas Nomeações de Liderança Executiva
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. nomeado Presidente, CEO e CMO em exercício Joe Farmer nomeado CBO HONG KONG e BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- A Zenas BioPharma (“Zenas”), uma empresa biofarmacêutica...
Zenas BioPharma Mengumumkan Pelantikan Kepimpinan Eksekutif Baharu
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. Presiden yang dilantik, CEO dan Pemangku CMO Joe Farmer, CBO yang dilantik HONG KONG dan BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), sebuah syarikat...
Zenas BioPharma, 신규 경영진 영입 발표
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu (MD, Ph.D.) 사장 겸 최고경영책임자 및 최고의학책임자 직무대행으로 선임 Joe Farmer를 최고사업개발책임자로 선임 홍콩/미국 보스턴, May 03, 2021 (GLOBE NEWSWIRE) -- 크로스보더 (중국과 미국 소재) 바이오 제약사로 면역기반 치료제 개발 및 공급에 중점을 두고 있는 Zenas BioPharma...
Zenas BioPharma gibt Ernennungen neuer Führungskräfte bekannt
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. zum President, CEO und Acting CMO ernannt Joe Farmer zum CBO ernannt HONGKONG und BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma („Zenas“), ein internationales (in...
Zenas BioPharma 宣佈任命新的執行領導
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu MD, Ph.D. 獲任命為總裁、行政總裁兼代理醫務總監 Joe Farmer 獲任命出任業務總監 香港和波士頓, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma（「Zenas」）是一家致力開發和交付免疫治療的跨境（中美兩國）生物製藥公司，今天宣佈任命 Hua Mu, MD, Ph.D. 擔任總裁、行政總裁兼代理醫務總監，而...